Korea United to sell homegrown aceclofenac preparations to Europe
Korea United Pharm said that it has recently fulfilled the registration of drug master file (DMF) for its self-synthesized aceclofenac, a potent non-steroidal anti-inflammatory drug (NSAID), to t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
